Cargando…

Bio-artificial bone formation model with a radial-flow bioreactor for implant therapy—comparison between two cell culture carriers: porous hydroxyapatite and β-tricalcium phosphate beads

Bone grafting is necessary before dental implant treatment in patients with jaw bone defects. Currently, autologous bone grafting is a major burden on the patient. However, it is impossible to form a sufficient foundation for the implant with a bone-filling agent alone. It is, therefore, necessary t...

Descripción completa

Detalles Bibliográficos
Autores principales: Nomoto, Hideki, Maehashi, Haruka, Shirai, Misako, Nakamura, Mariko, Masaki, Takahiro, Mezaki, Yoshihiro, Park, Jonghyuk, Aizawa, Mamoru, Ohkawa, Kiyoshi, Yoshida, Kiyotsugu, Matsuura, Tomokazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315002/
https://www.ncbi.nlm.nih.gov/pubmed/30276761
http://dx.doi.org/10.1007/s13577-018-0218-x
_version_ 1783384186917224448
author Nomoto, Hideki
Maehashi, Haruka
Shirai, Misako
Nakamura, Mariko
Masaki, Takahiro
Mezaki, Yoshihiro
Park, Jonghyuk
Aizawa, Mamoru
Ohkawa, Kiyoshi
Yoshida, Kiyotsugu
Matsuura, Tomokazu
author_facet Nomoto, Hideki
Maehashi, Haruka
Shirai, Misako
Nakamura, Mariko
Masaki, Takahiro
Mezaki, Yoshihiro
Park, Jonghyuk
Aizawa, Mamoru
Ohkawa, Kiyoshi
Yoshida, Kiyotsugu
Matsuura, Tomokazu
author_sort Nomoto, Hideki
collection PubMed
description Bone grafting is necessary before dental implant treatment in patients with jaw bone defects. Currently, autologous bone grafting is a major burden on the patient. However, it is impossible to form a sufficient foundation for the implant with a bone-filling agent alone. It is, therefore, necessary to prepare hybrid artificial bone tissue containing osteoblasts and osteoclasts. In this study, mouse MC3T3-E1 pre-osteoblast cells and human embryonic-derived osteoblastic cell line hFOB1.19 were cultured in radial-flow bioreactors (RFB) to form three-dimensional artificial bone filled with porous beads of β-tricalcium phosphate (β-TCP) or hydroxyapatite (HA)—which are clinically used as bone-filling agents—as cell culture carriers. When circulation culturing was performed in the growth medium for the first 10–12 days, glucose consumption was increased in the cultures with HA beads in comparison to the cultures with β-TCP beads. When cultured in the differentiation culture medium during the second half of the culture period, the glucose consumption decreased in the culture with HA beads. A DNA microarray analysis suggested that osteogenesis progressed fast in three-dimensional culture filled with HA beads and that partly differentiation into osteoblasts was prominent in cultures with β-TCP beads. In the growth process of MC3T3-E1 cells, the vitamin A metabolism was also activated, the synthesis and degradation of retinoic acid was enhanced, and the metabolism of the same process decreased at the end of differentiation in three-dimensional cultures. Three-dimensional circulation culture in RFB is considered to be useful for the formation of hybrid bio-artificial bone tissue. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s13577-018-0218-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6315002
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer Japan
record_format MEDLINE/PubMed
spelling pubmed-63150022019-01-11 Bio-artificial bone formation model with a radial-flow bioreactor for implant therapy—comparison between two cell culture carriers: porous hydroxyapatite and β-tricalcium phosphate beads Nomoto, Hideki Maehashi, Haruka Shirai, Misako Nakamura, Mariko Masaki, Takahiro Mezaki, Yoshihiro Park, Jonghyuk Aizawa, Mamoru Ohkawa, Kiyoshi Yoshida, Kiyotsugu Matsuura, Tomokazu Hum Cell Research Article Bone grafting is necessary before dental implant treatment in patients with jaw bone defects. Currently, autologous bone grafting is a major burden on the patient. However, it is impossible to form a sufficient foundation for the implant with a bone-filling agent alone. It is, therefore, necessary to prepare hybrid artificial bone tissue containing osteoblasts and osteoclasts. In this study, mouse MC3T3-E1 pre-osteoblast cells and human embryonic-derived osteoblastic cell line hFOB1.19 were cultured in radial-flow bioreactors (RFB) to form three-dimensional artificial bone filled with porous beads of β-tricalcium phosphate (β-TCP) or hydroxyapatite (HA)—which are clinically used as bone-filling agents—as cell culture carriers. When circulation culturing was performed in the growth medium for the first 10–12 days, glucose consumption was increased in the cultures with HA beads in comparison to the cultures with β-TCP beads. When cultured in the differentiation culture medium during the second half of the culture period, the glucose consumption decreased in the culture with HA beads. A DNA microarray analysis suggested that osteogenesis progressed fast in three-dimensional culture filled with HA beads and that partly differentiation into osteoblasts was prominent in cultures with β-TCP beads. In the growth process of MC3T3-E1 cells, the vitamin A metabolism was also activated, the synthesis and degradation of retinoic acid was enhanced, and the metabolism of the same process decreased at the end of differentiation in three-dimensional cultures. Three-dimensional circulation culture in RFB is considered to be useful for the formation of hybrid bio-artificial bone tissue. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s13577-018-0218-x) contains supplementary material, which is available to authorized users. Springer Japan 2018-10-01 2019 /pmc/articles/PMC6315002/ /pubmed/30276761 http://dx.doi.org/10.1007/s13577-018-0218-x Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Research Article
Nomoto, Hideki
Maehashi, Haruka
Shirai, Misako
Nakamura, Mariko
Masaki, Takahiro
Mezaki, Yoshihiro
Park, Jonghyuk
Aizawa, Mamoru
Ohkawa, Kiyoshi
Yoshida, Kiyotsugu
Matsuura, Tomokazu
Bio-artificial bone formation model with a radial-flow bioreactor for implant therapy—comparison between two cell culture carriers: porous hydroxyapatite and β-tricalcium phosphate beads
title Bio-artificial bone formation model with a radial-flow bioreactor for implant therapy—comparison between two cell culture carriers: porous hydroxyapatite and β-tricalcium phosphate beads
title_full Bio-artificial bone formation model with a radial-flow bioreactor for implant therapy—comparison between two cell culture carriers: porous hydroxyapatite and β-tricalcium phosphate beads
title_fullStr Bio-artificial bone formation model with a radial-flow bioreactor for implant therapy—comparison between two cell culture carriers: porous hydroxyapatite and β-tricalcium phosphate beads
title_full_unstemmed Bio-artificial bone formation model with a radial-flow bioreactor for implant therapy—comparison between two cell culture carriers: porous hydroxyapatite and β-tricalcium phosphate beads
title_short Bio-artificial bone formation model with a radial-flow bioreactor for implant therapy—comparison between two cell culture carriers: porous hydroxyapatite and β-tricalcium phosphate beads
title_sort bio-artificial bone formation model with a radial-flow bioreactor for implant therapy—comparison between two cell culture carriers: porous hydroxyapatite and β-tricalcium phosphate beads
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315002/
https://www.ncbi.nlm.nih.gov/pubmed/30276761
http://dx.doi.org/10.1007/s13577-018-0218-x
work_keys_str_mv AT nomotohideki bioartificialboneformationmodelwitharadialflowbioreactorforimplanttherapycomparisonbetweentwocellculturecarriersporoushydroxyapatiteandbtricalciumphosphatebeads
AT maehashiharuka bioartificialboneformationmodelwitharadialflowbioreactorforimplanttherapycomparisonbetweentwocellculturecarriersporoushydroxyapatiteandbtricalciumphosphatebeads
AT shiraimisako bioartificialboneformationmodelwitharadialflowbioreactorforimplanttherapycomparisonbetweentwocellculturecarriersporoushydroxyapatiteandbtricalciumphosphatebeads
AT nakamuramariko bioartificialboneformationmodelwitharadialflowbioreactorforimplanttherapycomparisonbetweentwocellculturecarriersporoushydroxyapatiteandbtricalciumphosphatebeads
AT masakitakahiro bioartificialboneformationmodelwitharadialflowbioreactorforimplanttherapycomparisonbetweentwocellculturecarriersporoushydroxyapatiteandbtricalciumphosphatebeads
AT mezakiyoshihiro bioartificialboneformationmodelwitharadialflowbioreactorforimplanttherapycomparisonbetweentwocellculturecarriersporoushydroxyapatiteandbtricalciumphosphatebeads
AT parkjonghyuk bioartificialboneformationmodelwitharadialflowbioreactorforimplanttherapycomparisonbetweentwocellculturecarriersporoushydroxyapatiteandbtricalciumphosphatebeads
AT aizawamamoru bioartificialboneformationmodelwitharadialflowbioreactorforimplanttherapycomparisonbetweentwocellculturecarriersporoushydroxyapatiteandbtricalciumphosphatebeads
AT ohkawakiyoshi bioartificialboneformationmodelwitharadialflowbioreactorforimplanttherapycomparisonbetweentwocellculturecarriersporoushydroxyapatiteandbtricalciumphosphatebeads
AT yoshidakiyotsugu bioartificialboneformationmodelwitharadialflowbioreactorforimplanttherapycomparisonbetweentwocellculturecarriersporoushydroxyapatiteandbtricalciumphosphatebeads
AT matsuuratomokazu bioartificialboneformationmodelwitharadialflowbioreactorforimplanttherapycomparisonbetweentwocellculturecarriersporoushydroxyapatiteandbtricalciumphosphatebeads